PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch

Today's Daily Dose brings you news about NantKwest teaming up with ImmunityBio to accelerate the development of vaccines and therapeutics for COVID-19; Mersana's promising data in ovarian cancer and non-small cell lung adenocarcinoma trial and Arcus' 10-year partnership with Gilead, among others.

from RTT - Biotech https://ift.tt/36AqqjG
via IFTTT